RT Journal Article
SR Electronic
T1 Isolation of infected people and their contacts is likely to be effective against many short-term epidemics
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.07.20207845
DO 10.1101/2020.10.07.20207845
A1 Geffen, Nathan
A1 Low, Marcus
YR 2020
UL http://medrxiv.org/content/early/2020/10/09/2020.10.07.20207845.abstract
AB Background Isolation of infected people and their contacts may be an effective way to control outbreaks of infectious disease, such as influenza and SARS-CoV-2. Models can provide insights into the efficacy of contact tracing, coupled with isolating or quarantining at risk people.Methods We developed an agent-based model and simulated 15, 000 short term illnesses, with varying characteristics. For each illness we ran ten simulations on the following scenarios: (1) No tracing or isolation (None), (2) isolation of agents who have tested positive (Isolation), (3) scenario 2 coupled with minimal contact tracing and quarantine of contacts (Minimum), (4) scenario 3 with more effective contact tracing (Moderate), and (5) perfect isolation of agents who test positive and perfect tracing and quarantine of all their contacts (Maximum).Results The median total infections of the Isolation, Minimum, Moderate and Maximum scenarios were 80%, 40%, 17% and 4% of the no intervention scenario respectively.Conclusions Isolation of infected patients and quarantine of their contacts, even if moderately well implemented, is likely to substantially reduce the number of infections in an outbreak. Randomized controlled trials to confirm these results in the real world and to analyse the cost effectiveness of contact tracing and isolation during coronavirus and influenza outbreaks are warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding or payment receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code and data are available on Github. https://github.com/nathangeffen/ABM_CTI